Skip to main content

Displaying 25 - 36 of 569

Director Gorman Buys 20,000 Shares of DIS

May 10, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by James Gorman, executive chairman of Morgan Stanley and director of The Walt Disney Company $DIS.

Gorman bought 20,000 DIS shares, equivalent to $2.1 million.

Cormorant Reports a $10 Million EYPT Purchase

May 9, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Cormorant Asset Management.

The hedge fund reported a purchase of roughly $10 million in EyePoint Pharmaceuticals $EYPT.

Madison Avenue's Samaha Reports a $13 Million TBPH Buy

May 6, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Eli Samaha, founder and managing partner of Madison Avenue Partners LP.

Samaha and Madison Avenue reported a purchase of $13 million in Theravance Biopharma $TBPH.

CEO Griffin Reports a Million-Dollar SWKS Purchase

May 3, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today's list comes via two Form 4 filings by Liam K. Griffin, chief executive officer and president of Skyworks Solutions $SWKS.

Griffin reported a total purchase of roughly $1 million in SWKS shares.

COO Miller Buys 10,000 GSHD Shares

May 1, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The biggest insider buy on today's list comes via two Form 4 filings by Mark Miller, president and COO of Goosehead Insurance Inc $GSHD.

Miller reported the acquisition of 10,000 GSHD shares, equivalent to $580,650.

Insiders Report $1.6 Million in Combined HXL Buys

April 30, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The biggest insider buy on today's list comes via two Form 4 filings by the chairman, CEO, and president and one director of Hexcel Corporation $HXL.

Those two insiders reported a combined purchase of HLX with a total value of $1.6 million.

Director Bailey Reports a Million-Dollar BHVN Buy

April 26, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider transaction on today’s list is a Form 4 filing by Biohaven Pharmaceutical Holding Company Ltd $BHVN director Gregory Bailey.

Bailey bought 25,503 BHVN shares, equivalent to $999,169.